VoxNeuro
VoxNeuro offers a non-invasive, rapid cognitive health assessment that combines neuropsychological and cognitive tests with EEG-based brain performance software to objectively score cognitive function for over 20 clinical conditions.
Services
VoxNeuro provides a cognitive health assessment that employs a combination of neuropsychological and cognitive tests with EEG-based brain performance software. The assessment measures key cognitive biomarkers such as attention, concentration, information processing, and memory. The company offers the VoxNeuro CORE assessment, which is rapid, non-invasive, and reimbursable with established medical necessity. Training for office staff is provided, and the assessment does not require EEG technicians or neuropsychologists to administer.
Technology and Tools
VoxNeuro uses standard EEG equipment with a minimum number of electrodes, which can be either stationary or portable. The assessment process includes a suite of tests such as the Awake and Drowsy Test, Auditory Evoked Potential Test, Visual Evoked Potential Test, Attention and Concentration & Information Processing Test, and Memory Test. These assessments are supported by the company's cloud-based software, which instantly generates patient reports. VoxNeuro's assessments are further validated by their normative database across age and sex cohorts from 12 to 90 years old.
Applications in Clinical Conditions
VoxNeuro's cognitive health assessments are applicable to over 20 clinical conditions. These include concussion, schizophrenia, traumatic brain injury, major depressive disorder, neurodegenerative diseases, ADHD, and mild cognitive impairment. The assessments provide quantitative measures evaluated against a normative database, offering objective scoring of cognitive function.
Regulatory Compliance
VoxNeuro is registered with both the FDA and Health Canada and its solutions are available for use in clinical settings in the US and Canada. The company adheres to important privacy regulations, including the Personal Health Information Protection Act (PHIPA) in Canada and the Health Insurance Portability and Accountability Act (HIPAA) in the US. Their practices are designed to ensure compliance with these regulations, safeguarding patient information.
Intellectual Property
VoxNeuro holds U.S. Patent No. 11,278,230, which covers systems and methods for cognitive health assessment. This patent encompasses the use of EEG-based cognitive biomarkers and various neuropsychological tests to objectively measure cognitive function. The company’s IP protects its unique approach to cognitive health assessment, cementing its innovative methods in the industry.